March 21, 2018
Pierre Tremblay, PhD
MabSelect PrismA
Pierre will introduce the next generation in Protein A chromatography, MabSelect PrismA. This resin demonstrates improved binding capacity in addition to enhanced alkaline stability. In conjunction to an improved high flow agarose base matrix, it provides the attributes for future mAb processing.
Pierre Tremblay has been with GE Healthcare for 15 years but started in protein purification as a graduate student. He supported and then lead the BioProcess courses in the GE portfolio, delivering custom courses at industry and academic sites.
